temporary defunctioning colostomy. This has subsequently been closed and the patient remains well. Histological examination of the resected specimen showed chronic ileitis with a transmural giant-cell granulomatous inflammatory reaction. Stains for acid-alcohol-fast organisms were negative and the features were considered to be those of Crohn's disease. There was no evidence of vasculitis in the mural or mesenteric vessels.
In view of these findings, the original skin biopsy was reviewed and necrotizing vasculitis in medium-sized dermal vessels confirmed. As noted in 1975, the vessel walls contained a giant-cell granulomatous infiltrate but additional stains have shown no destruction of the internal elastic lamina. With hindsight, it would have been more reasonable for the biopsy to have been reported as granulomatous vasculitis rather than polyarteritis nodosa.
Discussion
Clinicopathological correlation has reasonably excluded other known causes of granulomatous vasculitis and in this case appears to represent a cutaneous manifestation of Crohn's disease. Cutaneous manifestations of Crohn's disease occur in approximately 20% of patients (Dyer et al. 1970) . They include erythema nodosum, pyoderma gangrenosum, perianal skin tags and fistulae.
Vascular changes can occur in both pyoderma gangrenosum and erythema nodosum. Pyoderma gangrenosum may be a form of vasculitis but results to date are inconclusive. Erythema nodosum usually represents a granulomatous panniculitis, but septal vasculitis can be an additional feature. In addition, cutaneous necrotizing vasculitis has been described in association with idiopathic inflammatory bowel disease. It has been reported in occasional patients with ulcerative colitis (Callen 1979) and to date in a total of 8 patients with Crohn's disease (Dyer et al 1970) , Verbov & Stansfield 1972 , Burgdorf& Orkin 1981 , Chalvardjian & Nethercott 1982 . In a series including 6 of these patients, the vascular changes were interpreted as representing coexistent cutaneous polyarteritis nodosa (Dyer et al. 1970 , Verbov & Stansfield 1972 . All 6 showed livedo reticularis but histological proof of vasculitis was obtained in only 3. It is of interest that in one case the inflammation was described as granulomatous. The remaining 2 of the 8 patients showed cutaneous granulomatous vasculitis and this was considered to be a manifestation of Crohn's disease (Burgdorf & Orkin 1981 , Chalvardjian & Nethercott 1982 . In both of these cases the diagnosis of Crohn's disease had been established 14 years previously. Granulomatous vasculitis can occasionally be seen in the intestinal lesions of Crohn's disease and it has been suggested that the reaction may represent an immune response to antigen localized within the vessel wall (Thompson 1983 ). However, complement and immunoglobulin have not been identified within the vessel walls of our case by immunoperoxidase stains, and this negative observation was also made in one of the previous cases of granulomatous vasculitis using immunofluorescence (Chalvardjian & Nethercott 1982 (Figure 2 ) was suggestive of ureteritis cystica and confirmed bilateral PUJ obstruction. Attempted retrograde insertion of double J diversion stents failed. Bilateral 8 FG percutaneous nephrostomy tubes were therefore inserted. Improvement in renal Antegrade perfusion studies confirmed that both PUJs were still obstructed and it was decided to treat percutaneously by inserting double J stents in an antegrade fashion. Under general anesthesia bilateral 26 FG transparenchymal -percutaneous tracks were established. Each PUJ was incised under direct vision using an optical urethrotome (Figure 3 ). This 'pyelolysis' enabled two 8 FG silicone double J stents to be inserted (Figure 4) . The nephrostomy tubes were left in situ both as a precaution against the blockage of the double J stents and to provide a means for further investigation.
Three months later there had been further improvement in renal function (urea 20 mmol/l, creatinine 0.55 mmol/l). Bilateral antegrade perfusion studies showed that free drainage occurred around the stents at the level of the PUJ with no significant rise in intrapelvic pressure at an infusion rate of 12 ml/min. The double J stents were removed, and the antegrade studies were repeated to confirm continued patency at the PUJ. The patient's renal function has remained stable for 6 months (Figure 5 ).
The concept of percutaneous pyelolysis was first described by Wickham & Kellet (1983) and Whitfield et al. (1983) . It relies upon the principle of the intubated ureterotomy described by Davis (1943) . A review of the first 28 patients treated by pyelolysis (Ramsay et al. 1984) suggested that the secondary cases were more successfully treated by this procedure than were the primary cases.
The division of PUJ obstruction into primary and secondary categories is by no means clear. Primary PUJ obstruction or idiopathic hydronephrosis is of unknown aetiology. Notley (1968) was able to show an increase in collagen infiltration in specimens excised during dismembered pyeloplasty, but it is not known whether these changes are primary, or secondary to preexisting obstruction. The lack of structural and pathological changes in the obstructed PUJ has led to the suggestion that the lesion in primary PUJ obstruction is principally physiological and therefore better treated by excision. Secondary PUJ obstruction occurs following surgical procedures attended by excessive fibrosis and cicatrization. Such pathology may be more amenable to treatment by incision, by analogy with other fibrotic strictures.
However, there is a group of elderly patients who present with PUJ obstruction without any antecedent surgery for hydronephrosis who are difficult to categorize. As exemplified by the present case, these patients respond to treatment by percutaneous pyelolysis and are in this respect more similar to patients with secondary PUJ obstruction.
We suggest that elderly patients presenting with PUJ obstruction, especially when complicated by general ill health or renal failure, may be more suitably treated by percutaneous pyelolysis and internal diversion than by conventional open surgery.
Replacement therapy in end-stage renal amyloidosis' R A Banks MD MRCP C R Tribe MA FRCPath H J 0 White MA FRCS P R Harrison MH MRCP J C Mackenzie BA FRCP Southmead General Hospital, Bristol BSIO SNB Systemic amyloidosis is a rare cause of chronic renal failure and accounted for 1.3% of all new patients admitted to European renal replacement programmes in 1978. We report the first patient with renal amyloidosis to receive treatment with maintenance haemodialysis, continuous ambulatory peritoneal dialysis (CAPD) and cadaver renal transplantation.
Case report
A 28-year-old man with bronchiectasis from childhood was referred for investigation of proteinuria. His creatinine clearance was 36 ml/minute and an intravenous pyelogram (IVP) was reported as chronic pyelonephritis with small kidneys. Repeated urine cultures failed to demonstrate significant pathogens. Urinary protein excretion of 7 g/day suggested a glomerular lesion but percutaneous renal biopsy was unsuccessful. His renal function deteriorated over a period of 4 years and he commenced chronic haemodialysis in July 1978. Vascular access was complicated by recurrent subcutaneous haemorrhage from arteriovenous fistulae and eventually a Goretex graft was inserted in his leg.
In December 1978 he received a cadaver renal transplant which resulted in normal renal function. After 2 years, however, his creatinine clearance had fallen to 20 ml/minute. A needle biopsy of the transplanted kidney suggested an interstitial nephritis from a viral infection and polyoma virus was found in the urine. There was no proteinuria. Three years after transplantation graft function had further deteriorated and he was started on CAPD in October 1981. Graft nephrectomy was not performed. Long-term ampicillin was necessary to reduce purulent sputum from his bronchiectasis but despite this he experienced 7 episodes of peritonitis in 18 months on CAPD. After repeated attempts, it proved impossible to completely withdraw the corticosteroids given as part of the immunosuppressive regimen for his transplant. A Synacthen test showed absent adrenal cortical function. He died following an episode of acute pancreatitis.
At necropsy amyloidosis was an unexpected finding and histology confirmed widespread systemic deposition of secondary (AA) amyloid protein. The adrenal glands were enlarged and extensively replaced by amyloid and there were bronchiectatic changes in both lungs. His original kidneys were small, firm and waxy. Using a quantitative assessment (Tribe et al. 1983 ), 78% of the area of a random sample of glomeruli was found to be replaced by amyloid protein. Previous biopsies were then re-examined in order to estimate the rate of amyloid involvement in the transplanted kidney. A section of renal cortex taken at the time of transplant was free of amyloid. The needle biopsy obtained 2 years later 'Accepted 22 March 1985 0141-0768/85/070593-02/$02.OO/O
